SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-04-032498
Filing Date
2004-03-02
Accepted
2004-03-01 20:51:28
Documents
4
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 CORTEX FORM 10-K/A (30 JUNE 2003) d10ka.htm 10-K/A 520392
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 1855
4 CERTIFICATION BY CEO PURSUANT TO RULE 13A-14(A)/15D-14(A) dex311.htm EX-31.1 10329
5 CERTIFICATION BY CFO PURSUANT TO RULE 13A-14(A)/15D-14(A) dex312.htm EX-31.2 10185
  Complete submission text file 0001193125-04-032498.txt   544715
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-16467 | Film No.: 04640911
SIC: 2834 Pharmaceutical Preparations